{
  "docId": "019de06f-d161-76c4-a82c-f8798221f05a",
  "docSlug": "07562321c221b7c64cf059a7c16e0756",
  "documentTitle": "NNIT | Mergers and Acquisitions Presentation Deck | 11 slides",
  "authorId": "nnit",
  "authorName": "NNIT",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2019-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 11,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de06f-d161-76c4-a82c-f8798221f05a/8",
  "deckHref": "/decks/019de06f-d161-76c4-a82c-f8798221f05a",
  "deckJsonHref": "/decks/019de06f-d161-76c4-a82c-f8798221f05a.json",
  "deckAnchorHref": "/decks/019de06f-d161-76c4-a82c-f8798221f05a#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.045,
        "w": 0.46,
        "x": 0.515,
        "y": 0.205
      },
      "kind": "callout",
      "text": "Industry Associations Contributions",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f3277be-2d8f-4ca4-91d3-a6a5aa089690",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Strengthens NNIT’s presence across a global pharma and biotech client portfolio; Enhances our joint ability to provide end-to-end life sciences transformational IT services; Leverages synergies benefitting both HGP and NNIT; Increases access to additional life sciences companies; Strategic fit strengthening NNIT’s presence in the European life sciences hubs and cultural fit as employees share a deep understanding of IT compliance and regulatory requirements for life sciences companies",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98df893b-858e-429e-a4b8-5165fa548cea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.46,
        "x": 0.515,
        "y": 0.26
      },
      "kind": "list",
      "text": "ISPE and GAMP: HGP consultants have conducted validation projects according to GAMP (VMAN II) since 1993; HGP consultants are active members of the international and regional IPSE and GAMP forums; Members and contributors to several ISPE and GAMP Special Interest Groups (SIG). Pharma MES (MES & Process Minds): Member of the Advisory Board, Conference Chair. OPEN-SCS (Serialization Communications Standard) Workgroup (OPC Foundation): Membership, Operations Director. PDA (Parental Drug Association): Treasurer (PDA Singapore Chapter); Member of the Organization Committee for the PDA Conference Singapore",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d51ad112-4225-488a-a693-00ce494f701b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.05,
        "y": 0.08
      },
      "kind": "title",
      "text": "How does the transaction create value?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be95aa52-6fe5-40b6-87de-5da99649390e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 8,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ce389cba-3ab9-410f-9b99-34a369cb6a19",
      "evidence": "Slide 7: We are acquiring HGP to further boost international life sciences and Slide 8: How does the transaction create value?",
      "position": 0,
      "objective": "What are the benefits of acquiring HGP?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}